BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 463045)

  • 1. [Administration of 15-(S)-15-methyl prostaglandins F2 alpha in intrauterine fetal death, missed abortion and hydatidiform mole (author's transl)].
    Husslein P; Reinold E
    Wien Klin Wochenschr; 1979 Jun; 91(13):458-60. PubMed ID: 463045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missed abortion, hydatidiform mole and intra-uterine fetal death treated with 15-methyl-prostaglandin F 2-alpha.
    Boes EG
    S Afr Med J; 1980 Nov; 58(22):878-80. PubMed ID: 7434122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative studies on the termination of intact and disturbed pregnancies by intramuscular application of 15(s)-15-methyl-prostaglandin F2alpha (author's transl)].
    Schridde H; Hickl EJ
    Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):845-8. PubMed ID: 700344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with sulprostone (author's transl)].
    Brabec W; Dapunt O; Bichler A
    Wien Klin Wochenschr; 1981 Mar; 93(6):193-7. PubMed ID: 7281695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of missed abortion, intrauterine death and hydatidiform mole using prostaglandin E2.
    Murray CP; Clinch J
    Ir Med J; 1975 Mar; 68(6):133-5. PubMed ID: 1120656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induction of labor in missed abortion, fetal death and vesicular mole, using PGF2 alpha by extra-amniotic intracavitary administration].
    Paladini A; Di Lieto A; Martinelli P; De Placido G; Di Meglio A
    Minerva Ginecol; 1977 Dec; 29(12):931-8. PubMed ID: 609402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction of internal abortion and vesicular mole with intramuscular administration of 15(S)15-methyl-prostaglandin F2alpha].
    Nasi A; De Murtas M; Bianchi V; Mela S; Tomasi C; Silva A
    Minerva Ginecol; 1982 Jun; 34(6):461-6. PubMed ID: 7133532
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug treatment of retained abortion, intrauterine death of the fetus and of vesicular mole with 15-ME-PGF2alpha].
    Granese D; Pullè C; Carroccio G; Scurria L; Benedetto V; Silva A
    Minerva Ginecol; 1982 Jun; 34(6):467-74. PubMed ID: 7133533
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of prostaglandin E2 vaginal suppository in missed abortion, intrauterine death and hydatidiform mole.
    Takagi LR; Gulling EA; O'Leary JA
    J Med Assoc Ga; 1978 Aug; 67(8):644-5. PubMed ID: 574529
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of labour with sulprostone after foetal death and in hydatidiform mole.
    Saarikoski S; Selander K; Pystynen P
    Prostaglandins; 1980 Sep; 20(3):481-5. PubMed ID: 7422894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Termination of abnormal intrauterine pregnancies with intramuscular administration of dihomo 15 methyl prostaglandin F 2alpha.
    Karim SM; Ratnam SS
    Br J Obstet Gynaecol; 1976 Nov; 83(11):885-9. PubMed ID: 990229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missed abortion treated with intramuscular 15-(S)-15-methyl-prostaglandin F2 alpha.
    Tsalacopoulos G; Bloch B; Rush JM
    S Afr Med J; 1982 May; 61(22):828-30. PubMed ID: 7079904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of prostaglandin E 2 in the management of intrauterine death, missed abortion and hydatidiform mole.
    Filshie GM
    J Obstet Gynaecol Br Commonw; 1971 Jan; 78(1):87-90. PubMed ID: 5557677
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prostaglandin therapy in gynecology].
    Hickl EJ; Bandilla P; Kaether M
    Dtsch Med Wochenschr; 1974 Jul; 99(30):1566-8. PubMed ID: 4847141
    [No Abstract]   [Full Text] [Related]  

  • 15. A prostaglandin analogue (ONO-802) in treatment of missed abortion, intrauterine fetal death and hydatiform mole: a dose-finding trial.
    Garcea N; Dargenio R; Panetta V; Moneta E; Tancredi G; Giannitelli A
    Eur J Obstet Gynecol Reprod Biol; 1987 May; 25(1):15-22. PubMed ID: 3595971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
    Schmidt-Gollwitzer K; Schüssler B; Elger W; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of prostaglandin E2 in the management of missed abortion, missed labour, and hydatidiform mole.
    Karim SM
    Br Med J; 1970 Jul; 3(5716):196-7. PubMed ID: 5448780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of abortion by intra-amniotic administration of prostaglandin F2 alpha in patients with intrauterine fetal death and missed abortion.
    Antsaklis A; Diakomanolis E; Karayannopoulos C; Aravantinos D; Kaskarelis D
    Int Surg; 1979; 64(5):41-3. PubMed ID: 299443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of PGF 2-alpha in obstetrics].
    Lo Dico G; Milia S; Gigliotti B; Firinu C; Stoppelli I
    Minerva Ginecol; 1979 Oct; 31(10):709-20. PubMed ID: 545183
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic induction of abortion in the 1st and 2nd trimesters with intramuscular 15-methyl-prostaglandin F2 alpha].
    Göretzlehner G; Rudolf K; Frahm R
    Zentralbl Gynakol; 1977; 99(22):1356-60. PubMed ID: 602503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.